Gosuranemab
Gosuranemab Uses, Dosage, Side Effects, Food Interaction and all others data.
Gosuranemab is under investigation in clinical trial NCT02460094 (Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy).
| Trade Name | Gosuranemab |
| Generic | Gosuranemab |
| Gosuranemab Other Names | BMS-986168, Gosuranemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Gosuranemab
